Article
The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls.
BMC cancer - 13 Sept 2011
Zhang Hongtuan, Xu Yong, Zhang Zhihong, Li Liang
Abstract excerpt
BACKGROUND: Genetic polymorphism of human 8-oxoguanine glycosylase 1 (hOGG1) Ser326Cys (rs1052133) has been implicated to alter the risk of prostate cancer, but the results are controversial. METHODS: Two investigators independently searched the Medline, and Cochrane Library up to June 7, 2011. Summary odds ratios (OR) and 95% confidence interval (CI) for Ser326Cys polymorphism and prostate cancer were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
